David M Simpson, MD
- PROFESSOR | Neurology, Neuromuscular Diseases
- Hospital Affiliation
- The Mount Sinai Hospital
- Neurology Faculty Practice Associates 212-241-8748212-241-8748
David M. Simpson, MD, FAAN, is Professor of Neurology at The Icahn School of Medicine at Mount Sinai, Department of Neurology. He is Director of the Neuromuscular Diseases Division, Director of the Clinical Neurophysiology Laboratories, and Director of the Neuro-AIDS Program.
Author of more than 300 publications, Dr. Simpson is the principal investigator for many research studies. He led the studies that demonstrated the safety and effectiveness of the high concentration capsaicin patch in the treatment of certain types of painful peripheral neuropathy.
Dr. Simpson also led a research team that performed and published the first placebo-controlled study demonstrating the safety and effectiveness of botulinum toxin in the treatment of post-stroke spasticity. Additional studies by Dr. Simpson's group demonstrated the superiority of botulinum toxin over oral anti-spasticity medications. He has also led several studies to enhance the technique of the botulinum toxin injection. Dr. Simpson has lectured and published extensively in this area and trained physicians in these injections throughout the world.
In addition to his spasticity studies, Dr. Simpson chaired a panel chartered by the American Academy of Neurology to develop evidence-based guidelines on the use of botulinum toxin for a wide range of neurological diseases, including movement disorders such as cervical dystonia and blepharospasm; pain, including migraine; and autonomic disorders, such as hyperhidrosis (excessive sweating).
Dr. Simpson is a member of the American Neurological Association and the American Pain Society. He is a Fellow of the American Academy of Neurology, and the American Academy of Neuromuscular and Electrodiagnostic Medicine. He is on the editorial board of AIDS Patient Care and Current HIV/AIDS Reports.
Am Board of Electrodiagnostic Medicine
Neurology, American Board of Psychiatry and Neurology
- Amyotrophic Lateral Sclerosis
- Bell's Palsy
- Botulinum Toxin Injections
- Brachial Plexopathy
- Carpal Tunnel Syndrome
- Cauda Equina Syndrome
- Charcot-Marie-Tooth Disease
- Chronic Inflammatory Demyelinating Neuropathy
- Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
- Chronic Neck Pain
- Complex Regional Pain Syndrome
- Cubital Tunnel Syndrome
- Diabetic Neuropathy
- Electrodiagnostic Testing (EMG/NCS)
- Essential Tremor
- Focal Dystonia
- Foot Drop
- Gaucher Disease
- Guillain-Barré Syndrome
- HIV Neuropathy
- HIV and AIDS
- Hemifacial Spasm
- Herniated Disk
- Inclusion Body Myositis
- Inflammatory Myopathy
- Limb Dystonia
- Low Back Pain
- Lumbar Radiculopathy
- Lyme Disease
- Mitochondrial Myopathy
- Mononeuropathy Multiplex
- Muscle Biopsy
- Myasthenia Gravis
- Nerve Biopsy
- Nerve Conduction Study
- Neuralgia/Post-Herpetic Neuralgia
- Paraneoplastic Syndrome
- Periodic Paralysis Syndrome
- Peripheral Neuropathy
- Peroneal Nerve Injury
- Post-Polio Syndrome
- Progressive Multifocal Leukoencephalopathy
- Sensory Ganglionopathy
- Skin Biopsy
- Small Fiber Neuropathy
- Spinal Stenosis
- Tardive Dyskinesia
- Temporal Arteritis
- Thoracic Outlet Syndrome
- Toxic Myopathy
- Trigeminal Neuralgia
- Ulnar Neuropathy
- Writers' Cramp
HIV/AIDS, Immune Deficiency, Infectious Disease, Motor Control, Neurology, Neuromuscular System, Neurophysiology, Neurotoxicology, Rehabilitation, Spinal Cord, Stroke, Viruses and Virology
MD, S.U.N.Y, Buffalo - School of Med & Biomed Sciences
New York Presbyterian - Weill Cornell Medical Center
Residency, Internal Medicine
University Hospitals of Cleveland
Massachusetts General Hospital
America’s Top Doctors (Castle Connolly Medical)
Mitchell B Max Award in Neuropathic Pain
American Academy of Neurology
Best Doctors in New York, New York Magazine
Fellow of the Royal College of Physicians
Royal College of Physicians and Surgeons of Canada Service Award
Alpha Omega Alpha
James A. Gibson Anatomical Society
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.
Below are financial relationships with industry reported by Dr. Simpson during 2018 and/or 2019. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
- Acorda Therapeutics Inc.
- Allergan, Inc.
- Astellas Pharma Inc.
- Biogen Idec
- Merz Pharmaceuticals, LLC
Industry-Sponsored Lectures: MSSM faculty occasionally give lectures at events sponsored by industry, but only if the events are free of any marketing purpose
- Allergan, Inc.
Scientific Advisory Board:
- Acorda Therapeutics Inc.
- Allergan, Inc.
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.
Physicians who provide services at hospitals and facilities in the Mount Sinai Health System might not participate in the same health plans as those Mount Sinai hospitals and facilities (even if the physicians are employed or contracted by those hospitals or facilities).
Information regarding insurance participation and billing by this physician may be found on this page, and can also be obtained by contacting this provider directly. Because physicians insurance participation can change, the insurance information on this page may not always be up-to-date. Please contact this physician directly to obtain the most up-to-date insurance information.
Insurance and health plan networks that the various Mount Sinai Health System hospitals and facilities participate in can be found on the Mount Sinai Health System website.